Kyron T 134 represents a premium pharmaceutical-grade polymer specifically developed as a taste masking agent for oral drug formulations. This cross-linked acrylic acid polymer in potassium ionic form meets stringent USP/NF and EP compliance standards, ensuring high purity and safety for pharmaceutical applications. The polymer's unique chemical structure enables effective interaction with bitter drug molecules, creating a protective barrier that prevents taste receptor activation while maintaining complete drug efficacy. This advanced technology addresses the critical challenge of patient compliance by significantly improving medication palatability without compromising therapeutic performance.
The pharmaceutical industry extensively utilizes Kyron T 134 across multiple oral dosage forms where taste masking is essential for patient adherence. It serves as a vital component in pediatric syrups, suspensions, chewable tablets, and orally disintegrating formulations, particularly for dru...
Kyron T 134 represents a premium pharmaceutical-grade polymer specifically developed as a taste masking agent for oral drug formulations. This cross-linked acrylic acid polymer in potassium ionic form meets stringent USP/NF and EP compliance standards, ensuring high purity and safety for pharmaceutical applications. The polymer's unique chemical structure enables effective interaction with bitter drug molecules, creating a protective barrier that prevents taste receptor activation while maintaining complete drug efficacy. This advanced technology addresses the critical challenge of patient compliance by significantly improving medication palatability without compromising therapeutic performance.
The pharmaceutical industry extensively utilizes Kyron T 134 across multiple oral dosage forms where taste masking is essential for patient adherence. It serves as a vital component in pediatric syrups, suspensions, chewable tablets, and orally disintegrating formulations, particularly for drugs with inherently bitter profiles. The polymer demonstrates excellent compatibility with various drug classes including macrolide antibiotics, fluoroquinolones, antimalarials, antivirals, and essential mineral supplements. Its consistent performance makes it an indispensable excipient for pharmaceutical companies aiming to meet global regulatory standards while enhancing patient experience, especially in populations where medication taste significantly impacts treatment compliance.
For pharmaceutical manufacturers and suppliers, Kyron T 134 delivers substantial value through proven reliability and consistent performance. Its compliance with major international pharmacopeias simplifies regulatory approval processes for finished products, accelerating market entry. The polymer's effectiveness directly correlates with improved patient compliance rates, potentially enhancing the commercial success of medications. The consistent batch-to-batch quality ensures formulation stability and manufacturing efficiency, providing partners with a competitive advantage in delivering patient-friendly pharmaceutical solutions that meet evolving market demands for better-tasting medications.
Key Features:
- Cross-linked acrylic acid polymer in potassium ionic form for optimal performance
- Full compliance with USP/NF and EP pharmacopeial standards
- Specifically engineered for effective bitter taste masking in oral formulations
- Broad compatibility with diverse active pharmaceutical ingredients
- Consistent batch-to-batch quality ensuring formulation reliability
Benefits:
- Enhances patient compliance through effective taste concealment
- Meets global regulatory standards for easier market approval
- Maintains drug stability and bioavailability during taste masking
- Suitable for sensitive patient populations including pediatric and geriatric
- Provides reliable performance across various dosage forms and drug types